PolyPeptide Group AG (XSWX:PPGN) Other Operating Expense : CHF19.6 Mil (TTM As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is PolyPeptide Group AG Other Operating Expense?

PolyPeptide Group AG's Other Operating Expense for the six months ended in Dec. 2023 was CHF21.2 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 was CHF19.6 Mil.

PolyPeptide Group AG's quarterly Other Operating Expense declined from Dec. 2022 (CHF20.1 Mil) to Jun. 2023 (CHF-1.5 Mil) but then increased from Jun. 2023 (CHF-1.5 Mil) to Dec. 2023 (CHF21.2 Mil).

PolyPeptide Group AG's annual Other Operating Expense declined from Dec. 2021 (CHF20.1 Mil) to Dec. 2022 (CHF19.2 Mil) but then increased from Dec. 2022 (CHF19.2 Mil) to Dec. 2023 (CHF19.7 Mil).

PolyPeptide Group AG Other Operating Expense Historical Data

The historical data trend for PolyPeptide Group AG's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PolyPeptide Group AG Other Operating Expense Chart

PolyPeptide Group AG Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Operating Expense

Get a 7-Day Free Trial

14.57

16.23

20.11

19.17

19.70

PolyPeptide Group AG Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Other Operating Expense	Get a 7-Day Free Trial					23.16	-0.98	20.11	-1.51	21.15

PolyPeptide Group AG Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was CHF19.6 Mil.

PolyPeptide Group AG Other Operating Expense Related Terms

Thank you for viewing the detailed overview of PolyPeptide Group AG's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

PolyPeptide Group AG (XSWX:PPGN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PolyPeptide Group AG (XSWX:PPGN) » Definitions » Other Operating Expense

Comparable Companies

Traded in Other Exchanges

PPGNz:UK

Address

Neuhofstrasse 24, Baar, Zug, CHE, 6340

Website

https://www.polypeptide.com

PolyPeptide Group AG is an independent contract development and manufacturing organization (CDMO) focused on peptides and oligonucleotides employed as an active pharmaceutical ingredients (APIs) and used as intermediates in therapeutic products. The company derives a majority of its revenue from Europe and Asia.

PolyPeptide Group AG (XSWX:PPGN) Headlines

No Headlines